menu
    • menu

    Company profile for StrideBio

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    StrideBio, Inc. is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies. Our STRucture Inspired DEsign approach holds the potential to generate unique AAV capsids capable of overcoming the challenges of pre-existing neutralizing antibodies in patients. This powerful new approach has broad application, enabling gene addition, gene silencing and gene editing modalities ...
    StrideBio, Inc. is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies. Our STRucture Inspired DEsign approach holds the potential to generate unique AAV capsids capable of overcoming the challenges of pre-existing neutralizing antibodies in patients. This powerful new approach has broad application, enabling gene addition, gene silencing and gene editing modalities for rare diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    StrideBioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5 Laboratory Drive Suite 1200 Research Triangle Park, NC 27709
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://stridebio.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/stridebio
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ginkgo snaps up gene therapy vector assets from StrideBio
    Ginkgo snaps up gene therapy vector assets from StrideBio

    06 Apr 2023

    // Tyler Patchen ENDPTS

    https://endpts.com/ginkgo-snaps-up-gene-therapy-vector-assets-from-stridebio/

    Tyler Patchen ENDPTS
    06 Apr 2023
    Share Share
    StrideBio Announces Mark Velleca, M.D., Ph.D., as Chief Executive Officer
    StrideBio Announces Mark Velleca, M.D., Ph.D., as Chief Executive Officer

    04 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220204005062/en

    BUSINESSWIRE
    04 Feb 2022
    Share Share
    StrideBio Expands Leadership Team with Accomplished Industry Executives
    StrideBio Expands Leadership Team with Accomplished Industry Executives

    15 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210615005282/en

    BUSINESSWIRE
    15 Jun 2021
    Share Share
    StrideBio Announces Closing of $81.5M Series B Financing
    StrideBio Announces Closing of $81.5M Series B Financing

    16 Mar 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/stridebio-announces-closing-of-81-5m-series-b-financing-301247395.html

    PRNEWSWIRE
    16 Mar 2021
    Share Share
    Strides Pharma's Generic PREDNISONE Receives Approval In The US
    Strides Pharma's Generic PREDNISONE Receives Approval In The US

    13 Sep 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210785

    FDA
    13 Sep 2020
    Share Share
    Sarepta brings in more gene therapies with StrideBio deal
    Sarepta brings in more gene therapies with StrideBio deal

    15 Nov 2019

    // J. Gardner BOSPECTRUMASIA

    https://www.biopharmadive.com/news/sarepta-stridebio-deal-gene-therapy-rare-disease-research/567344/

    J. Gardner BOSPECTRUMASIA
    15 Nov 2019
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search